Shots:
- Dalan Animal Health has developed shrimp vaccine for white spot syndrome virus (WSSV) & early mortality syndrome (EMS) using its innate immunity platform, extending its validation from honeybee vaccine to aquaculture
- Dalan’s shrimp vaccine (administered via the broodstock) will offer non-GMO as well as non-chemical alternative to conventional vaccines & has shown 62% & 61% absolute survival to WSSV & EMS, respectively
- Platform aims to provide broad-spectrum, lifetime prevention against new diseases across species, (incl. future potential in vertebrate) by utilizing once-considered non-specific, trainable potential of innate immunity
Ref: Prnewswire | Image: Dalan Animal Health
Related News:- Anivive Lifesciences Receives $20M Funding from Leonid Capital Partners to Develop Novel Programs for Pets
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
